Roger E - Search Results

1

Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery.

Roger E, Lagarce F, Garcion E, Benoit JP. Roger E, et al. Nanomedicine (Lond). 2010 Feb;5(2):287-306. doi: 10.2217/nnm.09.110. Nanomedicine (Lond). 2010. PMID: 20148639 Review.

2

Evidence of residual micellar structures in a lipid nanocapsule dispersion. A multi-technique approach.

Roger E, Franconi F, Do TAT, Simonsson C, Siegler B, Perrot R, Saulnier P, Gimel JC. Roger E, et al. J Control Release. 2023 Dec;364:700-717. doi: 10.1016/j.jconrel.2023.10.054. Epub 2023 Nov 18. J Control Release. 2023. PMID: 37951474

3

Thymoquinone-loaded lipid nanocapsules with promising anticancer activity for colorectal cancer.

Selmi M, Salek A, Barboura M, Njim L, Trabelsi A, Lahmar A, Lautram N, Roger E, Baati T, Ghedira LC. Selmi M, et al. Among authors: roger e. Nanoscale Adv. 2023 Aug 22;5(19):5390-5398. doi: 10.1039/d3na00445g. eCollection 2023 Sep 26. Nanoscale Adv. 2023. PMID: 37767034 Free PMC article.

4

The gastrointestinal stability of lipid nanocapsules.

Roger E, Lagarce F, Benoit JP. Roger E, et al. Int J Pharm. 2009 Sep 11;379(2):260-5. doi: 10.1016/j.ijpharm.2009.05.069. Epub 2009 Jun 12. Int J Pharm. 2009. PMID: 19524655

5

Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.

Hureaux J, Lagarce F, Gagnadoux F, Vecellio L, Clavreul A, Roger E, Kempf M, Racineux JL, Diot P, Benoit JP, Urban T. Hureaux J, et al. Among authors: roger e. Eur J Pharm Biopharm. 2009 Oct;73(2):239-46. doi: 10.1016/j.ejpb.2009.06.013. Epub 2009 Jun 26. Eur J Pharm Biopharm. 2009. PMID: 19560538 Free article.

6

Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.

Roger E, Lagarce F, Garcion E, Benoit JP. Roger E, et al. J Control Release. 2009 Dec 3;140(2):174-81. doi: 10.1016/j.jconrel.2009.08.010. Epub 2009 Aug 20. J Control Release. 2009. PMID: 19699246

7

Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells.

Roger E, Lagarce F, Garcion E, Benoit JP. Roger E, et al. Eur J Pharm Sci. 2010 Aug 11;40(5):422-9. doi: 10.1016/j.ejps.2010.04.015. Epub 2010 May 11. Eur J Pharm Sci. 2010. PMID: 20438839

8

The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.

Huynh NT, Roger E, Lautram N, Benoît JP, Passirani C. Huynh NT, et al. Among authors: roger e. Nanomedicine (Lond). 2010 Nov;5(9):1415-33. doi: 10.2217/nnm.10.113. Nanomedicine (Lond). 2010. PMID: 21128723 Review.

9

Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration.

Roger E, Lagarce F, Benoit JP. Roger E, et al. Eur J Pharm Biopharm. 2011 Sep;79(1):181-8. doi: 10.1016/j.ejpb.2011.01.021. Epub 2011 Feb 12. Eur J Pharm Biopharm. 2011. PMID: 21303693

10

How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability?

Malhaire H, Gimel JC, Roger E, Benoît JP, Lagarce F. Malhaire H, et al. Among authors: roger e. Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):320-336. doi: 10.1016/j.addr.2016.03.011. Epub 2016 Apr 4. Adv Drug Deliv Rev. 2016. PMID: 27058155 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters